HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 13, 2024 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Dec 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a routine 6-K report on Dec 13, 2024, confirming its status as a foreign private issuer.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 13, 2024. This report is for the month of December 2024 and is filed as a report of a foreign private issuer. The company is incorporated in E9 and its principal executive offices are located in Hong Kong.
Why It Matters
This filing indicates ongoing reporting requirements for HUTCHMED as a foreign private issuer, providing transparency to investors about its corporate activities.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former Company Name
- 001-37710 (company) — SEC File Number
- 20241213 (date) — Filing Date
FAQ
What type of filing is HUTCHMED (China) Limited submitting?
HUTCHMED (China) Limited is submitting a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on December 13, 2024.
What is the SEC File Number for HUTCHMED (China) Limited?
The SEC File Number for HUTCHMED (China) Limited is 001-37710.
What is the principal executive office address for HUTCHMED (China) Limited?
The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under cover of Form 20-F.
Filing Stats: 170 words · 1 min read · ~1 pages · Grade level 14 · Accepted 2024-12-13 06:05:12
Filing Documents
- hcm-20241213x6k.htm (6-K) — 20KB
- hcm-20241213xex99d1.htm (EX-99.1) — 61KB
- hcm-20241213xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000097.txt ( ) — 88KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED to receive milestone payment from Takeda following first European reimbursement for FRUZAQLA (fruquintinib) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 13, 2024 3